NTLA 10-Q: SEC filing

Intellia Therapeutics

Filed with the SEC on Nov 5, 2026 · accession 0001193125-26-449862

NTLA filed a 10-Q (quarterly report) with the SEC on Nov 5, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -9.8% by the first close after the filing.

Summary of the filing

Intellia Therapeutics filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing a new $200 million credit facility with OrbiMed entered in September 2026.

For details, click here →How to read a 10-Q →

Key details

OrbiMed 2026 credit facility maximum borrowing$200.0M

FilerIntellia Therapeutics, Inc.

Lender under 2026 credit facilityOrbiMed

How NTLA stock reacted

Close before

$12.31

Nov 4, 2026

First close after

-9.83%

$11.10

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for NTLA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for NTLA?

Click here

Frequently asked questions

What did NTLA file with the SEC on Nov 5, 2026?

NTLA filed a 10-Q (SEC filing). Intellia Therapeutics filed its Q3 2026 Form 10-Q, reporting quarterly financial results and disclosing a new $200 million credit facility with OrbiMed entered in September 2026.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did NTLA stock react to this filing?

NTLA closed at $12.31 before the filing and $11.10 on Nov 5, 2026 (-9.83%).

Other NTLA SEC filings

Get alerts when NTLA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

NTLA overview NTLA analysis NTLA news Latest SEC filings